AB 1501 makes a package of regulatory changes for physician assistants (PAs) and podiatrists. It extends the statutory existence of the Podiatric Medical Board and the Physician Assistant Board to January 1, 2030; raises the number of PAs a physician may supervise; adjusts multiple licensing fees; revises credentialing rules for out‑of‑state podiatrists; and tightens renewal verification for PA licenses.
The bill shifts how some educational approvals are recognized (leaning on national accreditation), inserts an explicit state policy that podiatrists must be treated as doctors rather than ancillary providers for reimbursement and classification purposes, and asks for a stakeholder review of PA practice agreement structures. Several technical cross‑references and minor statutory cleanups are included.
At a Glance
What It Does
AB 1501 extends the two boards’ statutory life to 2030, increases the cap on physician supervision of physician assistants, changes how physician assistant training programs are recognized, revises multiple fee schedules for both professions, and mandates electronic renewal with a legal verification for PAs. It also removes a 10‑year examination recency requirement for out‑of‑state podiatrist credentialing and adds the term “podiatric surgeon” to unlawful title provisions.
Who It Affects
Licensed physician assistants and podiatrists in California; physicians who supervise PAs; the Physician Assistant Board and Podiatric Medical Board; training programs accredited nationally; employers (hospitals, clinics, health systems) that manage PA teams; and insurers and reimbursement administrators affected by podiatrist classification.
Why It Matters
The supervision cap and regulatory recognition changes alter workforce capacity and oversight. Fee and credentialing changes affect licensure costs and mobility. The podiatrist classification language has potential downstream implications for billing and provider networks; the bill also signals legislative intent to revisit practice agreement models with stakeholders.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill keeps the Podiatric Medical Board and the Physician Assistant Board in place until January 1, 2030, removing the automatic sunset that would have triggered legislative review. For physician assistants, the statute raises the limit on how many PAs a single physician may supervise from four to eight and gives the Medical Board of California explicit authority to limit supervision to certain PA types or specialties.
That change is designed to increase clinical capacity under physician oversight while leaving room for targeted restrictions tied to specialty practice.
On education and credentialing, AB 1501 narrows the state board’s hands on approval of PA training programs and makes clear that programs accredited by nationally recognized accrediting bodies are deemed approved; the bill also eliminates a prior 10‑year recency requirement for certain podiatric credentialing exams used when licensing doctors of podiatric medicine by credential. The Podiatric Medical Board retains authority to set fees but the statute updates which fees are charged and raises the podiatry biennial renewal amount to a higher level.Licensing administration changes include requiring PA renewal applications be submitted on the board’s electronic (or other) form and mandating that the renewal include a legal verification under penalty of perjury.
The bill authorizes specific fee schedules for PAs (with legislatively set ceilings the boards may reach by regulation) and adjusts duplicate certificate and other administrative fees for podiatrists. AB 1501 also adds a statutory policy that podiatrists be treated as doctors of podiatric medicine rather than ancillary or allied health professionals for classification and insurance purposes, and it prohibits misuse of titles including “podiatric surgeon.”Finally, the law states legislative intent that practice agreement structures for PAs be the subject of a comprehensive review with stakeholders and authorizes the Physician Assistant Board to collaborate with the Legislature to inform that work.
The bill includes a small set of technical amendments and a repeal of a superseded statutory provision for PAs to tidy the Physician Assistant Practice Act.
The Five Things You Need to Know
Both the Physician Assistant Board and the Podiatric Medical Board are extended so their statutory provisions remain effective through January 1, 2030.
A supervising physician may now oversee up to eight physician assistants at one time, and the Medical Board of California can restrict supervision to particular PA types or specialties.
The bill sets specific fee amounts and caps for PAs: application $60 (can increase to $80), initial license $250 (can increase to $500), biennial renewal $300 (can increase to $500), and a $50 fee for letters of endorsement or verification.
Podiatrists’ biennial renewal fee is increased to $1,900; the bill also removes the 10‑year recency requirement for certain national podiatric exams when licensing by credential.
PA renewal applications must be submitted on an electronic or other board form and include a legal verification signed under penalty of perjury, expanding the scope of criminal perjury law to license renewals.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Extend Podiatric Medical Board until 2030
Section 2460 now contains a sunset date of January 1, 2030 for the Podiatric Medical Board, preserving the board’s statutory existence and duties through that date. Practically, that delays any automatic termination and forces a future legislative review if changes are to be made after 2030.
Public‑protection priority and scope limits
The renumbered and amended provision reiterates that protection of the public is the board’s top priority. Section 2472 clarifies the statutory definition and permissible scope of podiatric practice — including limits on anesthesia to local only and explicit settings where ankle surgery is allowed (hospitals, approved surgical clinics, Medicare‑certified ASCs, and certain hospital outpatient facilities). These location and anesthetic constraints preserve institutional safety checks around more invasive podiatric procedures.
Title use and insurance classification
The statute makes it a misdemeanor to misuse podiatric titles and adds “podiatric surgeon” to the protected terms. It also contains a new explicit policy that doctors of podiatric medicine must be classified and treated as podiatric doctors and not as ancillary or allied health professionals in any health‑care setting or insurance reimbursement structure — language that will influence how payers and networks categorize podiatry services.
Credentialing and podiatry fees
The credentialing section removes the 10‑year exam recency constraint for applicants licensed in other states and lists the documentary requirements (education, exams, residency, discipline checks, databank report). The fees section rescales podiatry fees, most notably setting the biennial renewal at $1,900 and consolidating duplicate certificate and other administrative charges. The board still must keep fees within actual cost parameters.
Physician Assistant Board, accreditation recognition, and supervision
The Physician Assistant Board statute is extended to 2030 and made subject to legislative review on repeal. The bill narrows state review of PA educational programs by expressly recognizing programs approved by national accrediting organizations and instructs the board to set licensure standards and examinations. Critically, Section 3516 raises the cap on how many PAs a physician may supervise to eight and authorizes the Medical Board to restrict types of supervision by specialty.
PA fees and renewal verification
The PA fee schedule is detailed with set amounts and statutory maximums the board may reach by regulation; for example, application and renewal fees include legislatively defined ceilings. The bill repeals an older provision (3521.2) and requires that PA license renewals be submitted on the board’s electronic or other form and include a legal verification under penalty of perjury, making false statements on renewal a prosecutable offense.
Legislative intent to review practice agreements
The bill states legislative intent that practice agreement structures for PAs be reviewed with stakeholders and explicitly says the board may collaborate to inform future policy. The provision is nonbinding as to workload and is framed as an information and consultation mandate rather than a directive imposing new regulatory duties on the board.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients in underserved or high‑demand areas — increased supervision capacity (up to eight PAs per physician) can expand access to care and allow health systems to deploy PAs in more settings under physician oversight.
- Out‑of‑state podiatrists seeking California licensure — removing the 10‑year exam recency limit eases mobility for experienced practitioners who previously failed to meet that time window.
- Nationally accredited PA training programs — the board now deems nationally accredited programs approved, reducing duplicative state program‑level approval processes and smoothing program recognition.
Who Bears the Cost
- Individual physician assistants — the bill raises some licensing‑related fees and introduces a perjury verification on renewals, increasing both direct cost and legal exposure for licensees.
- Podiatrists — the biennial renewal fee is increased materially (to $1,900), raising ongoing practice costs that may be passed to patients or employers.
- Supervising physicians and employer compliance teams — supervising up to eight PAs increases managerial and oversight responsibilities, and institutions will need policies and possibly credentialing changes to track specialty restrictions and supervision limits.
Key Issues
The Core Tension
The central dilemma in AB 1501 is trade‑off between increasing access and workforce flexibility (by raising supervision caps and streamlining program recognition) and maintaining robust, proactive state oversight of clinical training, supervision quality, and public safety — a shift that delegates more practical risk management to employers, the Medical Board’s discretionary enforcement, and payers rather than prescribing detailed state controls.
The bill balances expanding workforce capacity against preserving regulatory controls, but implementation will raise difficult administrative and oversight questions. Increasing the supervisory cap to eight PAs assumes that systems and physicians can maintain adequate supervision; it also shifts some oversight burdens from numerical caps to the Medical Board’s discretionary power to restrict certain supervision relationships — a reliance on post‑hoc restrictions rather than proactively tailored supervision rules.
Health systems will need to formalize supervision protocols, quality metrics, and risk management to avoid patient safety gaps.
Shifting educational approval toward deference to national accreditors simplifies state processing but reduces direct state oversight of program content and clinical training quality. If California has specific competency concerns (e.g., local practice patterns or public‑health needs), they will need to be addressed through licensure standards and board examinations rather than program approvals.
Fee increases fund board operations but create access and equity questions: higher renewal fees may disproportionately affect early‑career clinicians or those in lower‑margin specialties. The added perjury verification tightens legal accountability, but raises enforcement questions and could discourage timely renewals if licensees fear criminal exposure for administrative errors.
Finally, the statutory push to classify podiatrists as doctors for reimbursement and administrative purposes creates downstream friction with insurers and existing provider‑network categorizations. Payers may resist reclassification or respond by adjusting reimbursement policies; disputes over provider status could require administrative or legal resolution and complicate contracting and billing in the near term.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.